Timothy MD - Dice Molecules Chief Officer
| DICEDelisted Stock | USD 47.55 0.00 0.00% |
Insider
Timothy MD is Chief Officer of Dice Molecules Holdings
| Age | 49 |
| Phone | 650 566 1402 |
| Web | https://www.dicemolecules.com |
Dice Molecules Management Efficiency
The company has return on total asset (ROA) of (0.1402) % which means that it has lost $0.1402 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.216) %, meaning that it created substantial loss on money invested by shareholders. Dice Molecules' management efficiency ratios could be used to measure how well Dice Molecules manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 13.27 M in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest the company is not taking enough advantage from borrowing. Dice Molecules Holdings has a current ratio of 23.14, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Dice Molecules until it has trouble settling it off, either with new capital or with free cash flow. So, Dice Molecules' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Dice Molecules Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Dice to invest in growth at high rates of return. When we think about Dice Molecules' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Chris Aiello | Amylyx Pharmaceuticals | N/A | |
| PharmD Chiodin | Day One Biopharmaceuticals | N/A | |
| Carrie MBA | Viridian Therapeutics | N/A | |
| Kerry MD | Terns Pharmaceuticals | N/A | |
| Badreddin Edris | Edgewise Therapeutics | 36 | |
| Rami Elghandour | Arcellx | 45 | |
| James MBA | Amylyx Pharmaceuticals | 57 | |
| Oxana Beskrovnaya | Dyne TherapeuticsInc | 63 | |
| Mike Preigh | Day One Biopharmaceuticals | N/A | |
| Gina Mazzariello | Amylyx Pharmaceuticals | 53 | |
| Karen Alderete | VaxcyteInc | N/A | |
| ric MD | Pliant TherapeuticsInc | 60 | |
| James Spudich | Cytokinetics | 82 | |
| Narinderjeet MS | Arcellx | 52 | |
| Kevin Capps | Crinetics Pharmaceuticals | N/A | |
| Dean MD | Pliant TherapeuticsInc | N/A | |
| FACC MD | Cytokinetics | 58 | |
| Darlene Noci | Nuvalent | 46 | |
| Shauna Horvath | Amylyx Pharmaceuticals | N/A | |
| Sbastien Desprez | Immunocore Holdings | N/A | |
| Michael Carruthers | Edgewise Therapeutics | 66 | |
Management Performance
| Return On Equity | -0.22 | |||
| Return On Asset | -0.14 |
Dice Molecules Holdings Leadership Team
Elected by the shareholders, the Dice Molecules' board of directors comprises two types of representatives: Dice Molecules inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Dice. The board's role is to monitor Dice Molecules' management team and ensure that shareholders' interests are well served. Dice Molecules' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dice Molecules' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kevin Judice, CEO Founder | ||
| Scott Robertson, Chief Officer | ||
| Timothy MD, Chief Officer | ||
| John Jacobsen, Chief Officer | ||
| Mary JD, G Counsel | ||
| Venkat Thalladi, VP CMC | ||
| Paul Fatheree, VP Chemistry |
Dice Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Dice Molecules a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.22 | |||
| Return On Asset | -0.14 | |||
| Current Valuation | 2.27 B | |||
| Shares Outstanding | 47.76 M | |||
| Shares Owned By Insiders | 3.15 % | |||
| Shares Owned By Institutions | 96.85 % | |||
| Number Of Shares Shorted | 4.88 M | |||
| Price To Book | 5.91 X | |||
| Price To Sales | 699.00 X | |||
| Gross Profit | (56.08 M) |
Pair Trading with Dice Molecules
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dice Molecules position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dice Molecules will appreciate offsetting losses from the drop in the long position's value.Moving together with Dice Stock
| 0.76 | ARTE | Artemis Strategic | PairCorr |
Moving against Dice Stock
| 0.76 | BA | Boeing Earnings Call Tomorrow | PairCorr |
| 0.59 | APAC | Stonebridge Acquisition Symbol Change | PairCorr |
| 0.45 | TRCA | Twin Ridge Capital | PairCorr |
The ability to find closely correlated positions to Dice Molecules could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dice Molecules when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dice Molecules - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dice Molecules Holdings to buy it.
The correlation of Dice Molecules is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dice Molecules moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dice Molecules Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dice Molecules can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Dice Molecules Holdings information on this page should be used as a complementary analysis to other Dice Molecules' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Dice Stock
If you are still planning to invest in Dice Molecules Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dice Molecules' history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |